Ground News

institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Gilead Sciences image

News about Gilead Sciences

Stay current with all the latest and breaking news about Gilead Sciences, compare headlines and perspectives between news sources on stories happening today. In total, 43stories have been published about Gilead Sciences which Ground News has aggregated in the past 3 months.

Covered Most By

Suggest a source

Local News Publishers

Suggest a source

Looking for a source we don't already have? Suggest one here.

Top Gilead Sciences News

FDA Approves HIV Drug Based on University of Utah Biochemist's Findings

FDA Approves HIV Drug Based on University of Utah Biochemist's Findings

60% Center coverage: 5 sources

Utah biochemist Wesley Sundquist has achieved yet another milestone with the Food and Drug Administration approval of an antiviral drug for HIV prevention based on his findings.See the Story

Trispecific Antibody Targeting HIV-1 and T Cells Activates and Eliminates Latently-Infected Cells in HIV/SHIV Infections

HIV · Democratic Republic of the Congo

Trispecific Antibody Targeting HIV-1 and T Cells Activates and Eliminates Latently-Infected Cells in HIV/SHIV Infections

67% Center coverage: 3 sources

Agents that can simultaneously activate latent HIV, increase immune activation and enhance the killing of latently-infected cells represent promising approaches for HIV cure. Here, we develop and evaluate a trispecific antibody (Ab), N6/αCD3-αCD28, that targets three independent proteins: (1) the HIV envelope via the broadly reactive CD4-binding site Ab, N6; (2) the T cell antigen CD3; and (3) the co-stimulatory molecule CD28. We find that the t…See the Story

FDA Loosens Restrictions on First-Gen CAR-T Therapies

Cancer · United States

FDA Loosens Restrictions on First-Gen CAR-T Therapies

100% Center coverage: 2 sources

There is enough experience with the first wave of autologous CAR-T therapies to allow strict rules ensuring their safe use to be relaxed, says FDA.See the Story

$100 Invested In First BanCorp 15 Years Ago Would Be Worth This Much Today - First BanCorp (NYSE:FBP)

100% Center coverage: 1 sources

First BanCorp (NYSE:FBP) has outperformed the market over the past 15 years by 15.29% on an annualized basis producing an average annual return of 27.71%. Currently, First BanCorp has a market capitalization of $3.54 billion. Buying $100 In FBP: If ... Full story available on Benzinga.comFinance · San Juan See the Story

$1000 Invested In Gilead Sciences 20 Years Ago Would Be Worth This Much Today - Gilead Sciences (NASDAQ:GILD)

100% Center coverage: 1 sources

Gilead Sciences Read Article

Only Two Shots a Year: First HIV Vaccine Gets FDA Approval

A milestone in preventing HIV, now available with each injection being good for 6 months each… Photo from Unsplash Yeztugo is the brand name for lenacapavir, a long acting injectable developed by Gilead Sciences. It is the first and only FDA approved HIV prevention option that requires two injections per year. This works by inhibiting the HIV capsid, a protein shell essential for viral replication that is blocking the virus at multiple stages of…Gilead Sciences · Cebu Read Article

Gilead Sciences: A Mixed Bag of Opportunities and Risks @themotleyfool #stocks $GILD

100% Left coverage: 1 sources

Gilead Sciences · Foster City Read Article

Nasdaq: Arm Holdings (+5.33%) and Gilead Sciences (+2.38%) Are the Highest Values

Gilead Sciences · Spain Read Article

Gilead Sciences and Unite for HER Launch Program to Support Metastatic Breast Cancer Patients

Gilead Sciences, Inc. has joined forces with Unite for HER (UFH) to introduce the Metastatic Breast Cancer Sustainer Program, a groundbreaking initiative aimed at providing free integrative care to Black, Hispanic, and underserved metastatic breast cancer patients across the United States. This program offers a range of services including acupuncture, professional counseling, personalized nutrition support, and fitness memberships, all at no cos…Gilead Sciences · United States Read Article

Transforming Communities: The Impact of Corporate Giving in Asia

Leading the Way in Corporate Philanthropy: Gilead Sciences in Asia As corporate social responsibility (CSR) gains prominence in business practices, Gilead Sciences stands out as a beacon of philanthropy within Asia. This biopharmaceutical leader has made significant contributions to combating infectious diseases while simultaneously prioritizing social impact. Through diverse initiatives and collaborations throughout the region,Gilead is tacklin…Gilead Sciences Read Article

Gilead Sciences facility video

100% Center coverage: 1 sources

Drugmaker Gilead Sciences shared file video from inside one of its facilities.Gilead Sciences · United States Read Article

Breaking News Topics Related to Gilead Sciences